Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

163.17
Delayed Data
As of Jul 21
 +3.84 / +2.41%
Today’s Change
71.46
Today|||52-Week Range
167.00
+121.49%
Year-to-Date
Vertex Pharmaceuticals Inc (VRTX) CEO & President Jeffrey M Leiden Sold $34.9 million...
Jul 21 / GuruFocus News - Paid Partner Content
The Zacks Analyst Blog Highlights: Apple, JPMorgan, Celgene, PayPal and Vertex Pharma...
Jul 19 / Zacks.com - Paid Partner Content
Is a Beat in the Cards for Vertex (VRTX) in Q2 Earnings?
Jul 21 / Zacks.com - Paid Partner Content
Vertex (VRTX) Triple Combination CF Studies Data Positive
Jul 19 / Zacks.com - Paid Partner Content
What's in the Offing for Bristol-Myers (BMY) in Q2 Earnings?
Jul 21 / Zacks.com - Paid Partner Content
Biotech Movers: Vertex Continues to Move on Data for CF Regimen
Jul 19 / TheStreet.com - Paid Partner Content
Vertex Pharma, A10 Networks, Microsoft, Visa and eBay highlighted as Zacks Bull and B...
Jul 21 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Vertex Boosted by CF Data, FDA Nod for Gilead, Puma Drugs
Jul 19 / Zacks.com - Paid Partner Content
Stock Market News for July 21, 2017
Jul 21 / Zacks.com - Paid Partner Content
Top Stock Reports for Apple, JPMorgan & Celgene
Jul 18 / Zacks.com - Paid Partner Content
Can Merck (MRK) Pull Off a Surprise this Earnings Season?
Jul 21 / Zacks.com - Paid Partner Content
Vertex Pharmaceuticals Stock Surging on Positive Trial Data
Jul 18 / TheStreet.com - Paid Partner Content
Seres Therapeutics (MCRB) Catches Eye: Stock Gains 9.2%
Jul 21 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Crescent Point Energy, Vertex Pharmaceuticals, Sod...
Jul 14 / Zacks.com - Paid Partner Content
Bull of the Day: Vertex Pharma (VRTX)
Jul 21 / Zacks.com - Paid Partner Content
Can Novartis (NVS) Spring a Surprise This Earnings Season?
Jul 14 / Zacks.com - Paid Partner Content
5 Stock Picks with Earnings Beat Potential
Jul 21 / Zacks.com - Paid Partner Content
5 Companies That Consistently Beat Earnings Estimates
Jul 13 / Zacks.com - Paid Partner Content
Why the Latest Vertex Pharmaceutical Data Is so Important
Jul 20 / GuruFocus News - Paid Partner Content
Amgen's Myeloma Drug Improves Overall Survival in Phase III
Jul 13 / Zacks.com - Paid Partner Content
Sarepta (SRPT) Q2 Loss Narrows, Ups Exondys 51 Sales View
Jul 20 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Vertex Pharmaceuticals, Alimera Sciences, Enzo Bio...
Jul 12 / Zacks.com - Paid Partner Content
Company News for July 20, 2017
Jul 20 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Arena Shoots Up on Study Data, CELG Inks Immuno-Oncology Deal ...
Jul 12 / Zacks.com - Paid Partner Content
Is Gilead (GILD) Poised for a Beat This Earnings Season?
Jul 20 / Zacks.com - Paid Partner Content
5 Top Multibagger Biotech Stocks to Buy in the 2nd Half
Jul 11 / Zacks.com - Paid Partner Content
Here's Why Vertex Pharmaceuticals (VRTX) Soared Today
Jul 19 / Zacks.com - Paid Partner Content
Zacks.com featured highlights: Sanderson Farms, American Woodmark, Vertex Pharmaceuti...
Jul 11 / Zacks.com - Paid Partner Content
Vertex Growth Expected to Continue with Life-Changing Cystic Fibrosis Treatment
Jul 19 / TheStreet.com - Paid Partner Content
5 Efficient Stocks to Buy for a Winning Portfolio
Jul 10 / Zacks.com - Paid Partner Content